We are live on
!
Find out more
SCM
Salem Capital Management Portfolio holdings
AUM
$126M
1-Year Est. Return
8.82%
This Fund
S&P 500
This Quarter
Est. Return
+4.38%
1 Year Est. Return
-8.82%
3 Year Est. Return
+32.26%
5 Year Est. Return
+45.09%
10 Year Est. Return
–
AUM
$182M
AUM Growth
+$8.9M
(+5.1%)
Cap. Flow
+$2.51M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
40.69%
Holding
70
New
3
Increased
15
Reduced
27
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams-Sonoma
WSM
|
+$4.42M |
| 2 |
BGG
Briggs & Stratton Corp.
BGG
|
+$452K |
| 3 |
Bank of America
BAC
|
+$336K |
| 4 |
JPMorgan Chase
JPM
|
+$209K |
| 5 |
Union Pacific
UNP
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$892K |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$526K |
| 3 |
STR
QUESTAR CORP
STR
|
+$273K |
| 4 |
Cintas
CTAS
|
+$245K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$228K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.16% |
| 2 | Technology | 15.12% |
| 3 | Industrials | 12.68% |
| 4 | Energy | 9.69% |
| 5 | Consumer Staples | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Eli Lilly
LLY
$995B
| $487K | 0.27% |
6,067
| – | – |
|
52
General Mills
GIS
$19.3B
| $485K | 0.27% |
7,600
-1,800
| -19% | -$125K |
|
53
Stryker
SYK
$129B
| $460K | 0.25% |
3,950
| – | – |
|
54
Southern Company
SO
$107B
| $408K | 0.22% |
7,950
-800
| -9% | -$42.1K |
|
55
Analog Devices
ADI
$185B
| $385K | 0.21% |
5,970
| – | – |
|
56
Duke Energy
DUK
$96.9B
| $288K | 0.16% |
3,602
| – | – |
|
57
RTX Corp
RTX
$294B
| $275K | 0.15% |
4,298
| – | – |
|
58
Wells Fargo
WFC
$267B
| $271K | 0.15% |
6,110
| – | – |
|
59
GSK
GSK
$103B
| $252K | 0.14% |
4,680
| – | – |
|
60
Sysco
SYY
$39.6B
| $245K | 0.13% |
5,000
| – | – |
|
61
Automatic Data Processing
ADP
$108B
| $238K | 0.13% |
2,700
| – | – |
|
|
62
Union Pacific
UNP
$176B
| $215K | 0.12% |
+2,200
| New | +$206K |
|
63
Amgen
AMGN
$210B
| $200K | 0.11% |
+1,200
| New | +$203K |
|
|
64
Bristol-Myers Squibb
BMY
$135B
| – | – |
-3,100
| Closed | -$228K |
|
65
Caterpillar
CAT
$404B
| – | – |
-2,700
| Closed | -$205K |
|
|
66
Cintas
CTAS
$81.5B
| – | – |
-10,000
| Closed | -$245K |
|
|
ESRX
67
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-2,845
| Closed | -$216K |
|
|
STR
68
DELISTED
QUESTAR CORP
STR
| – | – |
-10,750
| Closed | -$273K |
|
Similar funds
FFC
WC
SP
EVC
HGM
JSMC
RCM
DIV
Salem Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Salem Capital Management held 70 positions worth $182M, up 5.1% from $173M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Salem Capital Management's Q3 2016 filing shows 3 new, 15 increased, 27 reduced and 6 closed positions. Its largest new stake was Williams-Sonoma: 169,100 shares worth $4.32M. The largest sale was Novartis, an estimated $892K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.
- Salem Capital Management's largest Q3 2016 buy was Williams-Sonoma: 169,100 shares worth $4.32M.
- Salem Capital Management added most to Briggs & Stratton Corp. in Q3 2016, an estimated $452K increase.
- Salem Capital Management's biggest Q3 2016 reduction was Novartis, cutting an estimated $892K.
- Salem Capital Management fully exited QUESTAR CORP in Q3 2016, selling an estimated $273K.
- Salem Capital Management's ten largest holdings make up 41% of its $182M portfolio in Q3 2016.
- Salem Capital Management opened 3 new positions and closed 6 in Q3 2016.
- Salem Capital Management's portfolio value rose 5.1% quarter-over-quarter to $182M.
Based on Salem Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.